Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heike Bantel

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Hepatology (Baltimore, Md.)|February 9, 2017
The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realmMarcin Krawczyk, Monika Rau, Frank Grünhage, et al.
Clinical and Translational Gastroenterology|August 10, 2019
Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver StiffnessStephanie Liebig, Neele Stoeckmann, Andreas Geier, et al.
Hepatology (Baltimore, Md.)|August 21, 2007
Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liverXandra Volkmann, Ute Fischer, Matthias J Bahr, et al.
Scientific Reports|November 30, 2018
Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitisRichard Taubert, Jana Diestelhorst, Norman Junge, et al.
Journal of Hepatology|May 28, 2013
Autophagy-enhancing drug carbamazepine diminishes hepatocellular death in fibrinogen storage diseaseFlorian Puls, Imeke Goldschmidt, Heike Bantel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2015
Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the LiverMonika Rau, Anne-Kristin Schilling, Jan Meertens, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 29, 2011
Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI)Kinan Rifai, Janet Cornberg, Ingmar Mederacke, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 12, 2020
CK-18 cell death markers improve the prediction of histological remission in autoimmune hepatitis during biochemical remissionFinn C Derben, Bastian Engel, Kalliopi Zachou, et al.
Hepatology (Baltimore, Md.)|September 20, 2012
Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomibKristin Wahl, Martin Siegemund, Frank Lehner, et al.
Journal of Human Genetics|February 28, 2018
Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centersMarcin Krawczyk, Heike Bantel, Monika Rau, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Hepatology (Baltimore, Md.)|February 9, 2017
The ABCB4 p.T175A variant as potential modulator of hepatic fibrosis in patients with chronic liver diseases: Looking beyond the cholestatic realmMarcin Krawczyk, Monika Rau, Frank Grünhage, et al.
Clinical and Translational Gastroenterology|August 10, 2019
Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver StiffnessStephanie Liebig, Neele Stoeckmann, Andreas Geier, et al.
Hepatology (Baltimore, Md.)|August 21, 2007
Increased hepatotoxicity of tumor necrosis factor-related apoptosis-inducing ligand in diseased human liverXandra Volkmann, Ute Fischer, Matthias J Bahr, et al.
Scientific Reports|November 30, 2018
Increased seroprevalence of HAV and parvovirus B19 in children and of HEV in adults at diagnosis of autoimmune hepatitisRichard Taubert, Jana Diestelhorst, Norman Junge, et al.
Journal of Hepatology|May 28, 2013
Autophagy-enhancing drug carbamazepine diminishes hepatocellular death in fibrinogen storage diseaseFlorian Puls, Imeke Goldschmidt, Heike Bantel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2015
Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the LiverMonika Rau, Anne-Kristin Schilling, Jan Meertens, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 29, 2011
Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI)Kinan Rifai, Janet Cornberg, Ingmar Mederacke, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 12, 2020
CK-18 cell death markers improve the prediction of histological remission in autoimmune hepatitis during biochemical remissionFinn C Derben, Bastian Engel, Kalliopi Zachou, et al.
Hepatology (Baltimore, Md.)|September 20, 2012
Increased apoptosis induction in hepatocellular carcinoma by a novel tumor-targeted TRAIL fusion protein combined with bortezomibKristin Wahl, Martin Siegemund, Frank Lehner, et al.
Journal of Human Genetics|February 28, 2018
Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centersMarcin Krawczyk, Heike Bantel, Monika Rau, et al.
Pageof 11